MRSA in Pets and Vet Hospitals

Posted in These Categories: News of Hospital Acquired Infections

Medizone International, Inc. (OTCBB and OTCQB: MZEI) (http://medizoneint.com)

Heller and colleagues published a study in Risk Analysis (Qualitative Risk Assessment of the Acquisition of Meticillin-Resistant Staphylococcus aureus in Pet Dogs. Risk Analysis, 2010;30(3):458-472).

A qualitative risk assessment of the acquisition of meticillin-resistant Staphylococcus aureus (MRSA) in pet dogs, represents an important first step in the exploration of risk of bidirectional MRSA transfer between dogs and humans. A conceptual model of the seven potential pathways for MRSA acquisition in a dog in any given 24-hour period was developed and the data available to populate that model were considered qualitatively,” scientists in Wagga Wagga, Australia report.

“Humans were found to represent the most important source of MRSA for dogs in both community and veterinary hospital settings. The environment was found to be secondary to humans in terms of importance and other dogs less still. This study highlights some important methodological limitations of a technique that is heavily relied upon for qualitative risk assessments and applies a novel process, the use of relative risk ranking, to enable the generation of a defensible output using a matrix combination approach,” wrote J. Heller and colleagues, Charles Sturt University.

The researchers concluded: “Given the limitations of the prescribed methods as applied to the problem under consideration, further validation, or repudiation, of the findings contained herein is called for using a subsequent quantitative assessment.”

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospitals, sports training facilities, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures. Successful decontamination by AsepticSure™ to the 6 log standard or greater has been demonstrated with C.difficile, E coli, Pseudomonas aeruginous, MRSA, VRE and Bacillius subtilis.

Medizone International, Inc.
Post Office Box 742
Stinson Beach, CA 94970
Telephone: 415-868-0300
Fax: 415-868-2344

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Tweet This Post

Tags: MRSA pets